<li>amantadine<p>amantadine, bupropion. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Potential CNS toxicity d/t synergistic central dopamine effect.</p></li><li>amitriptyline<p>amitriptyline increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.<span><br><br></span>bupropion will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>amobarbital<p>amobarbital, bupropion. increasing metabolism. Use Caution/Monitor. Decr levels of bupropion, but incr levels of active metabolites. .</p></li><li>amoxapine<p>amoxapine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.<span><br><br></span>bupropion will increase the level or effect of amoxapine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>amphetamine<p>amphetamine increases toxicity of bupropion by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>aripiprazole<p>bupropion will increase the level or effect of aripiprazole by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>atomoxetine<p>bupropion will increase the level or effect of atomoxetine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>betaxolol<p>bupropion will increase the level or effect of betaxolol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>brexpiprazole<p>bupropion will increase the level or effect of brexpiprazole by  affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Administer half of the usual brexpiprazole dose when coadministered with strong CYP2D6 inhibitors. If also administered with a strong/moderate CYP3A4 inhibitor, administer a quarter of brexpiprazole dose. NOTE: In MDD clinical trials, brexpiprazole dosage was not adjusted for strong CYP2D6 inhibitors (eg, paroxetine, fluoxetine); thus, CYP considerations are already factored into general dosing recommendations and brexpiprazole may be administered without dosage adjustment in patients with MDD.</p></li><li>butabarbital<p>butabarbital, bupropion. increasing metabolism. Use Caution/Monitor. Decr levels of bupropion, but incr levels of active metabolites. .</p></li><li>butalbital<p>butalbital, bupropion. increasing metabolism. Use Caution/Monitor. Decr levels of bupropion, but incr levels of active metabolites. .</p></li><li>carvedilol<p>bupropion will increase the level or effect of carvedilol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>chloroquine<p>bupropion will increase the level or effect of chloroquine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>chlorpromazine<p>bupropion will increase the level or effect of chlorpromazine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>cinacalcet<p>bupropion will increase the level or effect of cinacalcet by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>citalopram<p>bupropion will increase the level or effect of citalopram by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>clomipramine<p>clomipramine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>clopidogrel<p>clopidogrel will increase the level or effect of bupropion by  affecting hepatic enzyme CYP2B6 metabolism. Use Caution/Monitor. Plasma concentrations of bupropion may be significantly increased when coadministered with clopidogrel or other CYP2B6 inhibitors. The increase in plasma bupropion concentrations may cause an increase in adverse reactions including tremor, headache, insomnia, dry mouth, nausea, or seizures.</p></li><li>codeine<p>bupropion will decrease the level or effect of codeine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. Prevents the conversion of codeine to its active metabolite morphine.</p></li><li>cyclosporine<p>cyclosporine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>desipramine<p>bupropion will increase the level or effect of desipramine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>desipramine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>dextroamphetamine<p>bupropion will increase the level or effect of dextroamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>dextroamphetamine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>dextromethorphan<p>bupropion will increase the level or effect of dextromethorphan by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>dosulepin<p>dosulepin increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>doxepin<p>bupropion will increase the level or effect of doxepin by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>doxepin increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>duloxetine<p>bupropion will increase the level or effect of duloxetine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>efavirenz<p>efavirenz will decrease the level or effect of bupropion by  increasing metabolism. Use Caution/Monitor. Coadministration with hepatic inducers reduced bupropion AUC and Cmax; hydroxybupropion (active metabolite) Cmax was increased </p></li><li>eluxadoline<p>bupropion increases levels of eluxadoline by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. As a precautionary measure due to incomplete information on the metabolism of eluxadoline, use caution when coadministered with strong CYP2D6 inhibitors.</p></li><li>elvitegravir/cobicistat/emtricitabine/tenofovir df<p>elvitegravir/cobicistat/emtricitabine/tenofovir df increases levels of bupropion by unknown mechanism. Use Caution/Monitor.</p></li><li>fesoterodine<p>bupropion will increase the level or effect of fesoterodine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>flecainide<p>bupropion will increase the level or effect of flecainide by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. Coadministration of bupropion and flecainide should be approached with caution and should be initiated at the lower end of the dose range of flecainide. If bupropion is added to the treatment regimen of a patient already receiving flecainide, consider decreasing the dose of flecainide.</p></li><li>flucloxacillin<p>flucloxacillin increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>fluoxetine<p>bupropion will increase the level or effect of fluoxetine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>fluphenazine<p>bupropion will increase the level or effect of fluphenazine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>galantamine<p>bupropion will increase the level or effect of galantamine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>haloperidol<p>bupropion will increase the level or effect of haloperidol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>hexobarbital<p>hexobarbital, bupropion. increasing metabolism. Use Caution/Monitor. Decr levels of bupropion, but incr levels of active metabolites. .</p></li><li>hydrocodone<p>bupropion will increase the level or effect of hydrocodone by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>iloperidone<p>bupropion will increase the level or effect of iloperidone by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>imipramine<p>bupropion will increase the level or effect of imipramine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>imipramine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>ioflupane i 123<p>bupropion decreases effects of ioflupane i 123 by receptor binding competition. Use Caution/Monitor. Drugs that bind to dopamine transporter receptor with high affinity may interfere with the image following ioflupane I 123 administration.</p></li><li>levodopa<p>bupropion increases effects of levodopa by pharmacodynamic synergism. Use Caution/Monitor. There is a higher incidence of adverse reactions with concurrent use of bupropion with levodopa. Use small initial dosages and small, gradual dosage increases of bupropion.</p></li><li>lisdexamfetamine<p>lisdexamfetamine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>lofepramine<p>bupropion will increase the level or effect of lofepramine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>lofepramine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>loratadine<p>bupropion will increase the level or effect of loratadine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>lumacaftor/ivacaftor<p>lumacaftor/ivacaftor, bupropion. affecting hepatic enzyme CYP2B6 metabolism. Use Caution/Monitor. In vitro studies suggest that lumacaftor may induce and ivacaftor may inhibit CYP2B6 substrates. .</p></li><li>lurasidone<p>lurasidone, bupropion.
Either increases toxicity of the other by Other (see comment). Use Caution/Monitor. 
Comment: Potential for increased CNS depressant effects when used concurrently; monitor for increased adverse effects and toxicity.</p></li><li>maprotiline<p>maprotiline increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.<span><br><br></span>bupropion will increase the level or effect of maprotiline by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>mephobarbital<p>mephobarbital, bupropion. increasing metabolism. Use Caution/Monitor. Decr levels of bupropion, but incr levels of active metabolites. .</p></li><li>methamphetamine<p>bupropion will increase the level or effect of methamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>methamphetamine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>methylenedioxymethamphetamine<p>methylenedioxymethamphetamine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>metoprolol<p>bupropion will increase the level or effect of metoprolol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>mexiletine<p>bupropion will increase the level or effect of mexiletine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>mianserin<p>mianserin increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>mifepristone<p>mifepristone will increase the level or effect of bupropion by  affecting hepatic enzyme CYP2B6 metabolism. Use Caution/Monitor.</p></li><li>mipomersen<p>mipomersen, bupropion.
Either increases toxicity of the other by Other (see comment). Use Caution/Monitor. 
Comment: Both drugs have potential to increase hepatic enzymes; monitor LFTs.</p></li><li>mirtazapine<p>bupropion will increase the level or effect of mirtazapine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>morphine<p>bupropion will increase the level or effect of morphine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>nebivolol<p>bupropion will increase the level or effect of nebivolol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>nelfinavir<p>nelfinavir, bupropion. decreasing metabolism. Use Caution/Monitor. Incr levels of bupropion, but decr levels of active metabolites. .</p></li><li>nilotinib<p>nilotinib, bupropion. increasing metabolism. Use Caution/Monitor. Decr levels of bupropion, but incr levels of active metabolites. .</p></li><li>nortriptyline<p>bupropion will increase the level or effect of nortriptyline by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>nortriptyline increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>oxycodone<p>bupropion will increase the level or effect of oxycodone by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>pentobarbital<p>pentobarbital, bupropion. increasing metabolism. Use Caution/Monitor. Decr levels of bupropion, but incr levels of active metabolites. .</p></li><li>perphenazine<p>bupropion will increase the level or effect of perphenazine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>perphenazine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>phenobarbital<p>phenobarbital will decrease the level or effect of bupropion by  increasing metabolism. Use Caution/Monitor. Decrease levels of bupropion.</p></li><li>pivmecillinam<p>pivmecillinam increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>primidone<p>primidone, bupropion. increasing metabolism. Use Caution/Monitor. Decr levels of bupropion, but incr levels of active metabolites. .</p></li><li>prochlorperazine<p>bupropion will increase the level or effect of prochlorperazine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.<span><br><br></span>prochlorperazine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>promethazine<p>bupropion will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>propafenone<p>bupropion will increase the level or effect of propafenone by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>propranolol<p>bupropion will increase the level or effect of propranolol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>protriptyline<p>protriptyline increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.<span><br><br></span>bupropion will increase the level or effect of protriptyline by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>risperidone<p>bupropion will increase the level or effect of risperidone by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>ritonavir<p>ritonavir decreases levels of bupropion by affecting hepatic enzyme CYP2B6 metabolism. Use Caution/Monitor. Ritonavir decreases levels of bupropion by inducing CYP2B6. Bupropion levels decreased by 20-80%, increased doses of bupropion may be required .</p></li><li>secobarbital<p>secobarbital, bupropion. increasing metabolism. Use Caution/Monitor. Decr levels of bupropion, but incr levels of active metabolites. .</p></li><li>sertindole<p>bupropion will increase the level or effect of sertindole by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>sertraline<p>sertraline increases levels of bupropion by affecting hepatic enzyme CYP2B6 metabolism. Use Caution/Monitor. Sertraline may inhibit hydroxylation of bupropion to its major active metabolite hydroxybupropion.<span><br><br></span>bupropion will increase the level or effect of sertraline by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>sorafenib<p>sorafenib, bupropion. decreasing metabolism. Use Caution/Monitor. Incr levels of bupropion, but decr levels of active metabolites. .</p></li><li>tamoxifen<p>bupropion decreases effects of tamoxifen by decreasing metabolism. Use Caution/Monitor. Inhibition of CYP2D6 metabolism to tamoxifen's active metabolite, endoxifen.<span><br><br></span>bupropion will decrease the level or effect of tamoxifen by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. Inhibition of CYP2D6 decreases metabolism of tamoxifen to active metabolite, endoxifen</p></li><li>tamsulosin<p>bupropion increases levels of tamsulosin by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>tapentadol<p>bupropion and tapentadol both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>temocillin<p>temocillin increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>ticarcillin<p>ticarcillin increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>timolol<p>bupropion will increase the level or effect of timolol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>tolterodine<p>bupropion will increase the level or effect of tolterodine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>tramadol<p>bupropion will increase the level or effect of tramadol by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>trifluoperazine<p>bupropion will increase the level or effect of trifluoperazine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>trimipramine<p>trimipramine increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.<span><br><br></span>bupropion will increase the level or effect of trimipramine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>venlafaxine<p>bupropion will increase the level or effect of venlafaxine by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>warfarin<p>bupropion increases effects of warfarin by unknown mechanism. Use Caution/Monitor. Altered PT/INR infrequently associated with hemorrhagic or thrombotic complications were observed when bupropion was administered with warfarin. Monitor INR when bupropion is added to existing warfarin regimen.</p></li>